Congressman ask for review of Bayer aspirin heart health claims
WASHINGTON Two Michigan democrats have singled out Bayer’s marketing of its Aspirin with Heart Advantage, a combination product that includes a dietary supplement, that appears to go against a Food and Drug Administration’s request not to advertise such products, said House of Representatives Energy and Commerce Chairman John Dingell, according to a Reuters report published Tuesday.
Dingell, along with Rep. Bart Stupak, fired off two letters suggesting that the supplement/analgesic combination product might need FDA approval—one to Bayer and the other to Health and Human Services secretary Michael Leavitt. HHS oversees the FDA.
Newly released pregnancy test tells gender of baby-to-be
SUNNYVALE, Calif. Consumer Genetics on Wednesday released a new pregnancy test kit that can also help identify the gender of the baby-to-be with a positive result.
As many as half of expectant parents want to know the gender of their child, the company stated, citing a 2007 Gallup Panel poll. Suggested retail price for the kit is $24.95.
Once a woman determines she is pregnant, she can use the included gender test kit as early as 7 weeks post-conception. The gender test involves a finger-prick blood sample for DNA collection and preservation. The kit is then mailed to the lab, with an additional lab fee of $199. Based on the company’s internal research study, the Consumer Genetics gender testing technology boasts slightly greater than 95 percent accuracy.
NACDS praises passing of legislation to curb methamphetamine production
ARLINGTON, Va. The National Association of Chain Drug Stores on Wednesday applauded the enactment of legislation designed to prevent the production and abuse of methamphetamines. President Bush signed into law the Methamphetamine Production Prevention Act (S. 1276) on Tuesday, securing a win for pharmacies and law enforcement, the association noted.
The bipartisan bill will facilitate the use and adoption of methamphetamine precursor electronic logbook systems, thus providing law enforcement with easier access to information and streamlining recordkeeping requirements for pharmacies.
“NACDS has worked extensively with the bill’s sponsors to ensure that the new requirements are effective and do not impose unnecessary burdens on pharmacies,” stated Steven Anderson, NACDS president and chief executive officer. “As a result, this is strong legislation that will assist retailers and law enforcement to combat the serious problem of illicit methamphetamine production and abuse.”